Dwayne C. Jones

Array ( [id] => 4075016 [patent_doc_number] => 05965585 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-10-12 [patent_title] => 'Method for the treatment of fibroproliferative disorders by application of inhibitors of protein hydroxylation' [patent_app_type] => 1 [patent_app_number] => 8/866998 [patent_app_country] => US [patent_app_date] => 1997-05-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 10764 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 123 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/965/05965585.pdf [firstpage_image] =>[orig_patent_app_number] => 866998 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3978138 [patent_doc_number] => 05917053 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-06-29 [patent_title] => 'Indole-2,3-dione-3-oxime derivatives, their preparation and use' [patent_app_type] => 1 [patent_app_number] => 8/809082 [patent_app_country] => US [patent_app_date] => 1997-05-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 7520 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 327 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/917/05917053.pdf [firstpage_image] =>[orig_patent_app_number] => 809082 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3934739 [patent_doc_number] => 05929114 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-07-27 [patent_title] => 'Arylthio compounds' [patent_app_type] => 1 [patent_app_number] => 8/857116 [patent_app_country] => US [patent_app_date] => 1997-05-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26048 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/929/05929114.pdf [firstpage_image] =>[orig_patent_app_number] => 857116 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4116247 [patent_doc_number] => 06046236 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-04-04 [patent_title] => 'Carbocyclic sulfonamides' [patent_app_type] => 1 [patent_app_number] => 8/848833 [patent_app_country] => US [patent_app_date] => 1997-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15319 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 413 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/046/06046236.pdf [firstpage_image] =>[orig_patent_app_number] => 848833 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3939925 [patent_doc_number] => 05981517 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-09 [patent_title] => 'Androstene derivatives' [patent_app_type] => 1 [patent_app_number] => 8/840038 [patent_app_country] => US [patent_app_date] => 1997-04-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23815 [patent_no_of_claims] => 69 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/981/05981517.pdf [firstpage_image] =>[orig_patent_app_number] => 840038 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3762564 [patent_doc_number] => 05852044 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-12-22 [patent_title] => 'Use of NK.sub.1 receptor antagonists for preparing cardio-regulatory drugs' [patent_app_type] => 1 [patent_app_number] => 8/845136 [patent_app_country] => US [patent_app_date] => 1997-04-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17932 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/852/05852044.pdf [firstpage_image] =>[orig_patent_app_number] => 845136 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3841508 [patent_doc_number] => 05847188 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-12-08 [patent_title] => 'Carbonate compounds, non-aqueous electrolytic solutions and batteries comprising non-aqueous electrolytic solutions' [patent_app_type] => 1 [patent_app_number] => 8/837349 [patent_app_country] => US [patent_app_date] => 1997-04-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 7581 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/847/05847188.pdf [firstpage_image] =>[orig_patent_app_number] => 837349 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4049608 [patent_doc_number] => 05968983 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-10-19 [patent_title] => 'Method and formulation for treating vascular disease' [patent_app_type] => 1 [patent_app_number] => 8/833842 [patent_app_country] => US [patent_app_date] => 1997-04-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 5100 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/968/05968983.pdf [firstpage_image] =>[orig_patent_app_number] => 833842 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3773793 [patent_doc_number] => 05849943 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-12-15 [patent_title] => 'Stilbene derivatives useful as cyclooxygenase-2 inhibitors' [patent_app_type] => 1 [patent_app_number] => 8/817128 [patent_app_country] => US [patent_app_date] => 1997-04-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11317 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 79 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/849/05849943.pdf [firstpage_image] =>[orig_patent_app_number] => 817128 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3769578 [patent_doc_number] => 05773431 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-06-30 [patent_title] => 'Administration of a 27-hydroxycholesterol or prodrug thereof as an anti-cancer agent' [patent_app_type] => 1 [patent_app_number] => 8/809435 [patent_app_country] => US [patent_app_date] => 1997-04-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 7669 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/773/05773431.pdf [firstpage_image] =>[orig_patent_app_number] => 809435 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4175430 [patent_doc_number] => 06083990 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-07-04 [patent_title] => 'Enhanced anti-angiogenic activity of permanently charged derivatives of steroid hormones' [patent_app_type] => 1 [patent_app_number] => 8/833074 [patent_app_country] => US [patent_app_date] => 1997-04-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 13 [patent_no_of_words] => 7413 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 255 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/083/06083990.pdf [firstpage_image] =>[orig_patent_app_number] => 833074 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1462969 [patent_doc_number] => 06350784 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-02-26 [patent_title] => 'Antimicrobial prevention and treatment of human immunedeficiency virus and other infectious diseases' [patent_app_type] => B1 [patent_app_number] => 08/824041 [patent_app_country] => US [patent_app_date] => 1997-03-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23040 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 365 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/350/06350784.pdf [firstpage_image] =>[orig_patent_app_number] => 08824041 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3762064 [patent_doc_number] => 05852016 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-12-22 [patent_title] => 'Quinoxaline derivatives useful in therapy' [patent_app_type] => 1 [patent_app_number] => 8/809337 [patent_app_country] => US [patent_app_date] => 1997-03-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26462 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 130 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/852/05852016.pdf [firstpage_image] =>[orig_patent_app_number] => 809337 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4185417 [patent_doc_number] => 06150422 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-11-21 [patent_title] => 'Stable gelled composition containing lipophilic active agents sensitive to oxygen and/or water' [patent_app_type] => 1 [patent_app_number] => 8/815428 [patent_app_country] => US [patent_app_date] => 1997-03-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2487 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/150/06150422.pdf [firstpage_image] =>[orig_patent_app_number] => 815428 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4010430 [patent_doc_number] => 05962472 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-10-05 [patent_title] => 'Use of 4-phenyl-3,6-dihydro-2H-pyridyl derivatives' [patent_app_type] => 1 [patent_app_number] => 8/813523 [patent_app_country] => US [patent_app_date] => 1997-03-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2898 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 128 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/962/05962472.pdf [firstpage_image] =>[orig_patent_app_number] => 813523 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4040082 [patent_doc_number] => 05856574 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-01-05 [patent_title] => 'Ortho-subsituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament containing them' [patent_app_type] => 1 [patent_app_number] => 8/804023 [patent_app_country] => US [patent_app_date] => 1997-02-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3553 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 108 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/856/05856574.pdf [firstpage_image] =>[orig_patent_app_number] => 804023 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3809756 [patent_doc_number] => 05811442 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-09-22 [patent_title] => 'Pharmaceutical compositions for the treatment of conditions associated with decreased blood flow' [patent_app_type] => 1 [patent_app_number] => 8/804224 [patent_app_country] => US [patent_app_date] => 1997-02-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14750 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/811/05811442.pdf [firstpage_image] =>[orig_patent_app_number] => 804224 [rel_patent_id] =>[rel_patent_doc_number] =>)